Anti-Angiogenic Activity of Flunarizine by In Ovo, In Vitro, and In Vivo Assays

Journal Title: Turkish Journal of Pharmaceutical Sciences - Year 2019, Vol 16, Issue 3

Abstract

Objectives: The involvement of T-type calcium channels in cell proliferation and the role of sodium channels in cell migration have been extensively studied in angiogenesis. In the present study, flunarizine, a dual sodium/calcium channel blocker; was selected to evaluate its anti-angiogenic potential. This can be therapeutically beneficial in diseases caused by pathologically excessive angiogenesis. Materials and Methods: The anti-angiogenic activity of ion channel blocker was screened by chick chorioallantoic membrane assay (in ovo), rat aortic ring assay, endothelial cell proliferation assay, transwell migration assay, Matrigel cord-like morphogenesis assay (in vitro), and sponge implantation method (in vivo). The anti-angiogenic activity of the test drug was compared with the standard anti-angiogenic drug bevacizumab and, in addition, the test responses were compared with the angiogenic factor vascular endothelial growth factor at a maximal concentration of 500 pM. Results: All the groups were compared with the control group using one-way ANOVA, followed by a post hoc test, Dunnett’s test, to compare the mean of all the groups with the control mean. In the chick chorioallantoic membrane assay, the number of branching points and angiogenic score were evaluated and significant results were observed at 10-5 M and 10-4 M. In the aortic ring assay a reduction in the area of sprouts was observed with 5-10 μM and significant reductions in the weight of sponges, number of blood vessels formed, and hemoglobin content were observed at all three tested concentrations of flunarizine in the sponge implantation method. In the studies on human umbilical vein endothelial cells the test drug (1-100 nM) showed significant inhibition of proliferation and migration and a decrease in the network length of cord-like tubes in a dose-dependent manner. Conclusion: Flunarizine has significant anti-angiogenic action by inhibiting cell proliferation, migration, and cord-like tube formation, which resulted from blocking of the T-type calcium and sodium channels. Further studies on the structural modifications of flunarizine for repurposing this ion channel modulator will lead to treatment of the diseases due to excessive angiogenesis from the root cause.

Authors and Affiliations

Chandana KAMILI*, Ravi Shankar KAKARAPARTHY, Uma Maheshwararao VATTIKUTI

Keywords

Related Articles

Nanocarriers Used Most in Drug Delivery and Drug Release: Nanohydrogel, Chitosan, Graphene, and Solid Lipid

Over the past few years, nanocarriers have become an ideal solution for safe and efficient drug delivery and release. This is mainly due to the extraordinary characteristics that nanomaterials exhibit when compared with...

Synthesis and Anticancer and Antimicrobial Evaluation of Novel Ether-linked Derivatives of Ornidazole

Objectives: Some novel 1-(2-methyl-5-nitro-1H-imidazol-1-yl)-3-(substituted phenoxy)propan-2-ol derivatives (3a-g) were designed and synthesized. Materials and Methods: Compounds 3a-g were obtained by refluxing ornidazo...

Evaluation of the Antioxidant Potency of Seseli L. Species (Apiaceae)

Objectives: In the present study, the antioxidant potency of ethyl acetate (AcOEt) and methanol (MeOH) extracts from the aerial parts of Seseli L. species was investigated for the first time. Materials and Methods: Sese...

Antimicrobial Potential of Bioactive Metabolites and Silver Nanoparticles from Bacillus spp. and of Some Antibiotics Against Multidrug Resistant Salmonella spp.

Objectives: The synthesis of nanoparticles using microorganisms and their metabolites is of increasing interest because they are potential producers of biocompatible and environmental friendly nanoparticles. Their nanopa...

Comparative Morphological and Anatomical Studies on Morus Species (Moraceae) in Turkey

Objectives: Morus alba L., Morus nigra L., and Morus rubra L. are widely cultivated in many countries due to their nutritive, economic, and medicinal value. In this study, comparative morphological and anatomical studies...

Download PDF file
  • EP ID EP48826
  • DOI 10.4274/tjps.galenos.2018.29981
  • Views 314
  • Downloads 0

How To Cite

Chandana KAMILI*, Ravi Shankar KAKARAPARTHY, Uma Maheshwararao VATTIKUTI (2019). Anti-Angiogenic Activity of Flunarizine by In Ovo, In Vitro, and In Vivo Assays. Turkish Journal of Pharmaceutical Sciences, 16(3), -. https://europub.co.uk/articles/-A-48826